Advanced

A consensus statement on clinical trials of bypassing agent prophylaxis in inhibitor patients.

Teitel, J; Berntorp, Erik LU ; Dolan, G; Fischer, K; Gringeri, A; Kessler, C; Lambert, T; Leissinger, C; Nemes, L and Shima, M (2011) In Haemophilia 17. p.516-521
Abstract
Summary. The haemophilia literature increasingly contains reports describing the use of bypassing agent prophylaxis (BAP) in patients with severe haemophilia A and inhibitors. However, it is difficult to interpret and compare the results and draw conclusions about treatment efficacy because of small patient numbers and a lack of standardization among BAP studies. This article presents consensus recommendations for standardizing future BAP clinical trials developed by an international panel of haemophilia opinion leaders.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Haemophilia
volume
17
pages
516 - 521
publisher
Federation of European Neuroscience Societies and Blackwell Publishing Ltd
external identifiers
  • wos:000289894200020
  • pmid:21371181
  • scopus:79955154649
ISSN
1351-8216
DOI
10.1111/j.1365-2516.2010.02440.x
language
English
LU publication?
yes
id
46151289-04c0-47cf-93ea-670d6af687a5 (old id 1884425)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/21371181?dopt=Abstract
date added to LUP
2011-04-01 12:10:36
date last changed
2017-01-01 07:29:38
@article{46151289-04c0-47cf-93ea-670d6af687a5,
  abstract     = {Summary. The haemophilia literature increasingly contains reports describing the use of bypassing agent prophylaxis (BAP) in patients with severe haemophilia A and inhibitors. However, it is difficult to interpret and compare the results and draw conclusions about treatment efficacy because of small patient numbers and a lack of standardization among BAP studies. This article presents consensus recommendations for standardizing future BAP clinical trials developed by an international panel of haemophilia opinion leaders.},
  author       = {Teitel, J and Berntorp, Erik and Dolan, G and Fischer, K and Gringeri, A and Kessler, C and Lambert, T and Leissinger, C and Nemes, L and Shima, M},
  issn         = {1351-8216},
  language     = {eng},
  pages        = {516--521},
  publisher    = {Federation of European Neuroscience Societies and Blackwell Publishing Ltd},
  series       = {Haemophilia},
  title        = {A consensus statement on clinical trials of bypassing agent prophylaxis in inhibitor patients.},
  url          = {http://dx.doi.org/10.1111/j.1365-2516.2010.02440.x},
  volume       = {17},
  year         = {2011},
}